ENAI Stock Chart & Stats
$0.03
$0.01(59.41%)
At close: 4:00 PM EDT
$0.03
$0.01(59.41%)
Day’s Range― - ―
52-Week Range$0.01 - $0.05
Previous CloseN/A
Volume431.00
Average Volume (3M)25.00
Market Cap
$643.71K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta51.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding19,991,076
10 Day Avg. Volume0
30 Day Avg. Volume25
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ENAI FAQ
What was Molecular Pharmacology (USA)’s price range in the past 12 months?
Molecular Pharmacology (USA) lowest stock price was $0.01 and its highest was $0.05 in the past 12 months.
What is Molecular Pharmacology (USA)’s market cap?
Molecular Pharmacology (USA)’s market cap is $643.71K.
When is Molecular Pharmacology (USA)’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Molecular Pharmacology (USA)’s earnings last quarter?
Currently, no data Available
Is Molecular Pharmacology (USA) overvalued?
According to Wall Street analysts Molecular Pharmacology (USA)’s price is currently Overvalued.
Does Molecular Pharmacology (USA) pay dividends?
Molecular Pharmacology (USA) does not currently pay dividends.
What is Molecular Pharmacology (USA)’s EPS estimate?
Molecular Pharmacology (USA)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Molecular Pharmacology (USA) have?
Molecular Pharmacology (USA) has 19,991,076 shares outstanding.
What happened to Molecular Pharmacology (USA)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Molecular Pharmacology (USA)?
Currently, no hedge funds are holding shares in ENAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Molecular Pharmacology (USA)
AI Energy Inc., a development stage company, focuses on discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound. The company was formerly known as Molecular Pharmacology (USA), Ltd. and changed its name to AI Energy Inc. in April 2026. The company is based in Shanghai, China.